市場調査レポート

商品コード

1139953

単一細胞分析市場：製品別、技術別、エンドユーザー別、用途別：世界の機会分析および産業予測、2021-2031年

Single Cell Analysis Market By Product, By Techniques, By End User, By Application : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2022年07月01日 | 発行: Allied Market Research

| ページ情報: 英文 270 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,570 560,989円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 5,730 900,412円

レポートPDFをご利用いただけるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDFl内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,508,544円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の単一細胞分析市場は、2021年に26億4150万米ドル、2031年には136億1676万米ドルに達し、2022年から2031年にかけてCAGR17.8%を記録すると予測されています。

単一細胞分析（SCA）は、集団の不均一性を示し、関心のある少数亜集団を特定し、個々の細胞の特定の形質について知るために不可欠です。マイクロ流体システムは、細胞の直径に近いスケールで操作できるため、単一細胞の操作に有用です。高密度に充填されたマイクロウェル内に個々の細胞を迅速かつ決定論的にトラップすることができるマイクロ流体アレイ。このトラッピングアレイは、流速が可変の複数のマイクロ流体サンプル処理ユニットと連結することができ、様々な単一細胞研究に利用できます。なぜなら、単一細胞のトラッピング効率は流速ではなくチャンネル設計によって決定されるからです。SCAは、植物生物学、出生前診断、微生物学、免疫学、神経科学などでも一般的に使用されています。

世界の単一細胞分析市場の成長を促す主な要因としては、単一細胞分析における技術的進歩や、製薬・バイオテクノロジー産業における研究開発の増加が挙げられます。さらに、幹細胞研究の成長、個別化医療への注目の高まり、癌の有病率の急増が市場成長をさらに後押ししています。しかし、単一細胞分析製品のコストが高いことが、予測期間中の単一細胞分析市場の成長を抑制すると予想されます。逆に、シングルセルシーケンスの高い成長ポテンシャルは、市場参入企業に有利な機会を提供すると予想されます。

概要
- 市場規模および予測
オンコロジー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
免疫学
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
神経学
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
幹細胞
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
非侵襲的出生前診断
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
体外受精（IVF）
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第6章単一細胞分析市場：技術別

概要
- 市場規模・予測
フローサイトメトリー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
次世代シーケンサー（NGS）
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
ポリメラーゼ連鎖反応（PCR）
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
質量分析計（Mass Spectrometry）
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第7章単一細胞分析市場：エンドユーザー別

概要
- 市場規模・予測
学術・研究機関
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
バイオテクノロジー企業、製薬企業
- 主要な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
病院・診断研究所
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第8章単一細胞分析市場：地域別

概要
- 市場規模・予測
北米
- 主な動向と機会
- 北米市場規模・予測：製品別
- 北米市場規模・予測：用途別
- 北米市場の市場規模・予測：技術別
- 北米市場の市場規模・予測：エンドユーザー別
- 北米市場規模・予測：国別
  - 米国
  - カナダ
  - メキシコ
欧州
- 主な動向と機会
- 欧州市場規模・予測：製品別
- 欧州市場規模・予測：用途別
- 欧州市場規模・予測：技術別
- 欧州市場規模・予測：エンドユーザー別
- 欧州市場規模・予測：国別
  - ドイツ
  - フランス
  - 英国
  - イタリア
  - スペイン
  - その他の欧州地域
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域の市場規模・予測：製品別
- アジア太平洋地域の市場規模・予測：用途別
- アジア太平洋地域の市場規模・予測：技法別
- アジア太平洋地域の市場規模・予測：エンドユーザー別
- アジア太平洋地域の市場規模・予測：国別
  - 日本
  - 中国
  - インド
  - オーストラリア
  - 韓国
  - その他アジア太平洋地域
LAMEA
- 主な動向と機会
- LAMEAの市場規模・予測：製品別
- LAMEAの市場規模・予測：用途別
- LAMEAの市場規模・予測：技法別
- LAMEAの市場規模・予測：エンドユーザー別
- LAMEAの市場規模・予測：国別
  - ブラジル
  - サウジアラビア
  - 南アフリカ
  - LAMEAの残りの地域

第9章企業情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合のヒートマップ
主な発展

第10章企業プロファイル

10x Genomics
Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories
Danaher Corporation（Cytiva Life Sciences）
Illumina, Inc.
BERKLEY LIGHTS INC
BGI GENOMICS CO. LTD
DIASORIN GROUP（LUMINEX CORPORATION）
DOLOMITE BIO
MERCK KGAA
OXFORD NANAOPORE TECHNOLOGIES
QIAGEN N.V
Sartorius AG
STANDARD BIOTOOLS（Fluidigm Corporation）
TAKARA HOLDINGS INC
THERMO FISHER SCIENTIFIC, INC.

図表

LIST OF TABLES

TABLE 1. GLOBAL SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. SINGLE CELL ANALYSIS MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
TABLE 3. SINGLE CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. SINGLE CELL ANALYSIS MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 5. SINGLE CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 7. SINGLE CELL ANALYSIS MARKET SIZE, FOR ONCOLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 8. SINGLE CELL ANALYSIS MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. SINGLE CELL ANALYSIS MARKET SIZE, FOR IMMUNOLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 10. SINGLE CELL ANALYSIS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. SINGLE CELL ANALYSIS MARKET SIZE, FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 12. SINGLE CELL ANALYSIS MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. SINGLE CELL ANALYSIS MARKET SIZE, FOR STEM CELL, BY REGION, 2021-2031 ($MILLION)
TABLE 14. SINGLE CELL ANALYSIS MARKET FOR STEM CELL, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. SINGLE CELL ANALYSIS MARKET SIZE, FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. SINGLE CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. SINGLE CELL ANALYSIS MARKET SIZE, FOR IN-VITRO FERTILIZATION (IVF), BY REGION, 2021-2031 ($MILLION)
TABLE 18. SINGLE CELL ANALYSIS MARKET FOR IN-VITRO FERTILIZATION (IVF), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. SINGLE CELL ANALYSIS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 20. SINGLE CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. GLOBAL SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 22. SINGLE CELL ANALYSIS MARKET SIZE, FOR FLOW CYTOMETRY, BY REGION, 2021-2031 ($MILLION)
TABLE 23. SINGLE CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 24. SINGLE CELL ANALYSIS MARKET SIZE, FOR NEXT GENERATION SEQUENCING (NGS), BY REGION, 2021-2031 ($MILLION)
TABLE 25. SINGLE CELL ANALYSIS MARKET FOR NEXT GENERATION SEQUENCING (NGS), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 26. SINGLE CELL ANALYSIS MARKET SIZE, FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2021-2031 ($MILLION)
TABLE 27. SINGLE CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION (PCR), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. SINGLE CELL ANALYSIS MARKET SIZE, FOR MASS SPECTROMETRY, BY REGION, 2021-2031 ($MILLION)
TABLE 29. SINGLE CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. SINGLE CELL ANALYSIS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 31. SINGLE CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. GLOBAL SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 33. SINGLE CELL ANALYSIS MARKET SIZE, FOR ACADEMIC AND RESEARCH LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 34. SINGLE CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 35. SINGLE CELL ANALYSIS MARKET SIZE, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2021-2031 ($MILLION)
TABLE 36. SINGLE CELL ANALYSIS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 37. SINGLE CELL ANALYSIS MARKET SIZE, FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 38. SINGLE CELL ANALYSIS MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. SINGLE CELL ANALYSIS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 40. SINGLE CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 41. SINGLE CELL ANALYSIS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 42. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 43. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 45. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 46. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 47. U.S. SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 48. U.S. SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 49. U.S. SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 50. U.S. SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. CANADA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. CANADA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. CANADA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 54. CANADA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 55. MEXICO SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. MEXICO SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. MEXICO SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 58. MEXICO SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 59. EUROPE SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 60. EUROPE SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 61. EUROPE SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 62. EUROPE SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. EUROPE SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 64. GERMANY SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. GERMANY SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. GERMANY SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 67. GERMANY SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 68. FRANCE SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 69. FRANCE SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. FRANCE SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 71. FRANCE SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. U.K. SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. U.K. SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. U.K. SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 75. U.K. SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. ITALY SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. ITALY SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 78. ITALY SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 79. ITALY SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. SPAIN SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. SPAIN SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. SPAIN SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 83. SPAIN SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 84. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 87. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 90. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 91. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 92. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 93. JAPAN SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 94. JAPAN SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 95. JAPAN SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 96. JAPAN SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 97. CHINA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 98. CHINA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 99. CHINA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 100. CHINA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 101. INDIA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 102. INDIA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 103. INDIA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 104. INDIA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 105. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 106. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 107. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 108. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 109. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 110. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 111. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 112. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 113. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 114. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 115. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 116. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 117. LAMEA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 118. LAMEA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 119. LAMEA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 120. LAMEA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 121. LAMEA SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 122. BRAZIL SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 123. BRAZIL SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 124. BRAZIL SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 125. BRAZIL SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 126. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 127. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 128. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 129. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 130. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 131. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 132. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 133. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 134. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 135. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 136. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 137. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 138.10X GENOMICS: COMPANY SNAPSHOT
TABLE 139.10X GENOMICS: OPERATING SEGMENTS
TABLE 140.10X GENOMICS: PRODUCT PORTFOLIO
TABLE 141.10X GENOMICS: NET SALES,
TABLE 142.10X GENOMICS: KEY STRATERGIES
TABLE 143.AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 144.AGILENT TECHNOLOGIES, INC.: OPERATING SEGMENTS
TABLE 145.AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 146.AGILENT TECHNOLOGIES, INC.: NET SALES,
TABLE 147.AGILENT TECHNOLOGIES, INC.: KEY STRATERGIES
TABLE 148.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 149.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 150.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 151.BECTON, DICKINSON AND COMPANY: NET SALES,
TABLE 152.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 153.BIO-RAD LABORATORIES: COMPANY SNAPSHOT
TABLE 154.BIO-RAD LABORATORIES: OPERATING SEGMENTS
TABLE 155.BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
TABLE 156.BIO-RAD LABORATORIES: NET SALES,
TABLE 157.BIO-RAD LABORATORIES: KEY STRATERGIES
TABLE 158.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): COMPANY SNAPSHOT
TABLE 159.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): OPERATING SEGMENTS
TABLE 160.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): PRODUCT PORTFOLIO
TABLE 161.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): NET SALES,
TABLE 162.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): KEY STRATERGIES
TABLE 163.ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 164.ILLUMINA, INC.: OPERATING SEGMENTS
TABLE 165.ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 166.ILLUMINA, INC.: NET SALES,
TABLE 167.ILLUMINA, INC.: KEY STRATERGIES
TABLE 168.BERKLEY LIGHTS INC: COMPANY SNAPSHOT
TABLE 169.BERKLEY LIGHTS INC: OPERATING SEGMENTS
TABLE 170.BERKLEY LIGHTS INC: PRODUCT PORTFOLIO
TABLE 171.BERKLEY LIGHTS INC: NET SALES,
TABLE 172.BERKLEY LIGHTS INC: KEY STRATERGIES
TABLE 173.BGI GENOMICS CO. LTD: COMPANY SNAPSHOT
TABLE 174.BGI GENOMICS CO. LTD: OPERATING SEGMENTS
TABLE 175.BGI GENOMICS CO. LTD: PRODUCT PORTFOLIO
TABLE 176.BGI GENOMICS CO. LTD: NET SALES,
TABLE 177.BGI GENOMICS CO. LTD: KEY STRATERGIES
TABLE 178.DIASORIN GROUP (LUMINEX CORPORATION): COMPANY SNAPSHOT
TABLE 179.DIASORIN GROUP (LUMINEX CORPORATION): OPERATING SEGMENTS
TABLE 180.DIASORIN GROUP (LUMINEX CORPORATION): PRODUCT PORTFOLIO
TABLE 181.DIASORIN GROUP (LUMINEX CORPORATION): NET SALES,
TABLE 182.DIASORIN GROUP (LUMINEX CORPORATION): KEY STRATERGIES
TABLE 183.DOLOMITE BIO: COMPANY SNAPSHOT
TABLE 184.DOLOMITE BIO: OPERATING SEGMENTS
TABLE 185.DOLOMITE BIO: PRODUCT PORTFOLIO
TABLE 186.DOLOMITE BIO: NET SALES,
TABLE 187.DOLOMITE BIO: KEY STRATERGIES
TABLE 188.MERCK KGAA: COMPANY SNAPSHOT
TABLE 189.MERCK KGAA: OPERATING SEGMENTS
TABLE 190.MERCK KGAA: PRODUCT PORTFOLIO
TABLE 191.MERCK KGAA: NET SALES,
TABLE 192.MERCK KGAA: KEY STRATERGIES
TABLE 193.OXFORD NANAOPORE TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 194.OXFORD NANAOPORE TECHNOLOGIES: OPERATING SEGMENTS
TABLE 195.OXFORD NANAOPORE TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 196.OXFORD NANAOPORE TECHNOLOGIES: NET SALES,
TABLE 197.OXFORD NANAOPORE TECHNOLOGIES: KEY STRATERGIES
TABLE 198.QIAGEN N.V: COMPANY SNAPSHOT
TABLE 199.QIAGEN N.V: OPERATING SEGMENTS
TABLE 200.QIAGEN N.V: PRODUCT PORTFOLIO
TABLE 201.QIAGEN N.V: NET SALES,
TABLE 202.QIAGEN N.V: KEY STRATERGIES
TABLE 203.SARTORIUS AG: COMPANY SNAPSHOT
TABLE 204.SARTORIUS AG: OPERATING SEGMENTS
TABLE 205.SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 206.SARTORIUS AG: NET SALES,
TABLE 207.SARTORIUS AG: KEY STRATERGIES
TABLE 208.STANDARD BIOTOOLS (FLUIDIGM CORPORATION): COMPANY SNAPSHOT
TABLE 209.STANDARD BIOTOOLS (FLUIDIGM CORPORATION): OPERATING SEGMENTS
TABLE 210.STANDARD BIOTOOLS (FLUIDIGM CORPORATION): PRODUCT PORTFOLIO
TABLE 211.STANDARD BIOTOOLS (FLUIDIGM CORPORATION): NET SALES,
TABLE 212.STANDARD BIOTOOLS (FLUIDIGM CORPORATION): KEY STRATERGIES
TABLE 213.TAKARA HOLDINGS INC: COMPANY SNAPSHOT
TABLE 214.TAKARA HOLDINGS INC: OPERATING SEGMENTS
TABLE 215.TAKARA HOLDINGS INC: PRODUCT PORTFOLIO
TABLE 216.TAKARA HOLDINGS INC: NET SALES,
TABLE 217.TAKARA HOLDINGS INC: KEY STRATERGIES
TABLE 218.THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 219.THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
TABLE 220.THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 221.THERMO FISHER SCIENTIFIC, INC.: NET SALES,
TABLE 222.THERMO FISHER SCIENTIFIC, INC.: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.SINGLE CELL ANALYSIS MARKET SEGMENTATION
FIGURE 2.SINGLE CELL ANALYSIS MARKET,2021-2031
FIGURE 3.SINGLE CELL ANALYSIS MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.SINGLE CELL ANALYSIS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.SINGLE CELL ANALYSIS MARKET,BY PRODUCT,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 15.SINGLE CELL ANALYSIS MARKET,BY APPLICATION,2021(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ONCOLOGY SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF IMMUNOLOGY SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF NEUROLOGY SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF STEM CELL SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE PRENATAL DIAGNOSIS SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF IN-VITRO FERTILIZATION (IVF) SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OTHERS SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 23.SINGLE CELL ANALYSIS MARKET,BY TECHNIQUES,2021(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING (NGS) SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF POLYMERASE CHAIN REACTION (PCR) SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF MASS SPECTROMETRY SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF OTHERS SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 29.SINGLE CELL ANALYSIS MARKET,BY END USER,2021(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF ACADEMIC AND RESEARCH LABORATORIES SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 31.COMPARATIVE SHARE ANALYSIS OF BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 32.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND DIAGNOSTIC LABORATORIES SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 33.COMPARATIVE SHARE ANALYSIS OF OTHERS SINGLE CELL ANALYSIS MARKET,2021-2031(%)
FIGURE 34.SINGLE CELL ANALYSIS MARKET BY REGION,2021
FIGURE 35.U.S. SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 36.CANADA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 37.MEXICO SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 38.GERMANY SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 39.FRANCE SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 40.U.K. SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 41.ITALY SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 42.SPAIN SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 43.REST OF EUROPE SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 44.JAPAN SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 45.CHINA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 46.INDIA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 47.AUSTRALIA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 48.SOUTH KOREA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 49.REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 50.BRAZIL SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 51.SAUDI ARABIA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 52.SOUTH AFRICA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 53.REST OF LAMEA SINGLE CELL ANALYSIS MARKET,2021-2031($MILLION)
FIGURE 54. TOP WINNING STRATEGIES, BY YEAR
FIGURE 55. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 56. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 57.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 58.COMPETITIVE DASHBOARD
FIGURE 59.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 60.10X GENOMICS.: NET SALES ,($MILLION)
FIGURE 61.AGILENT TECHNOLOGIES, INC..: NET SALES ,($MILLION)
FIGURE 62.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
FIGURE 63.BIO-RAD LABORATORIES.: NET SALES ,($MILLION)
FIGURE 64.DANAHER CORPORATION(CYTIVA LIFE SCIENCES).: NET SALES ,($MILLION)
FIGURE 65.ILLUMINA, INC..: NET SALES ,($MILLION)
FIGURE 66.BERKLEY LIGHTS INC.: NET SALES ,($MILLION)
FIGURE 67.BGI GENOMICS CO. LTD.: NET SALES ,($MILLION)
FIGURE 68.DIASORIN GROUP (LUMINEX CORPORATION).: NET SALES ,($MILLION)
FIGURE 69.DOLOMITE BIO.: NET SALES ,($MILLION)
FIGURE 70.MERCK KGAA.: NET SALES ,($MILLION)
FIGURE 71.OXFORD NANAOPORE TECHNOLOGIES.: NET SALES ,($MILLION)
FIGURE 72.QIAGEN N.V.: NET SALES ,($MILLION)
FIGURE 73.SARTORIUS AG.: NET SALES ,($MILLION)
FIGURE 74.STANDARD BIOTOOLS (FLUIDIGM CORPORATION).: NET SALES ,($MILLION)
FIGURE 75.TAKARA HOLDINGS INC.: NET SALES ,($MILLION)
FIGURE 76.THERMO FISHER SCIENTIFIC, INC..: NET SALES ,($MILLION)

Product Code: A06188

The global single cell analysis market was valued at $2,641.5 million in 2021, and is projected to reach $13,616.76 million by 2031, registering a CAGR of 17.8% from 2022 to 2031.

Single-cell analysis (SCA) is essential in order to show population heterogeneity, identify minority sub-populations of interest, and learn about the particular traits of individual cells. Microfluidic systems are useful for manipulating single cells since they operate at a scale similar to cell diameter. A microfluidic array capable of quickly and deterministically trapping individual cells in densely packed microwells. This trapping array can be linked with multiple microfluidic sample processing units with variable flow rates for various single-cell studies because the single-cell trapping efficiency is dictated by the channel design rather than the flow rate. SCA is also commonly used in plant biology, prenatal diagnostics, microbiology, immunology, and neuroscience.

The major factors that drive the growth of the global single cell analysis market include technological advancement in single cell analysis and increase in R&D in pharmaceutical and biotechnology industry. In addition, growth in stem cell research, growing focus on personalized medicines and surge in prevalence of cancer further propel the market growth. However, high cost of single cell analysis products is expected to restrain the growth of the single cell analysis market during the forecast period. Conversely, high growth potential of single cell sequencing is anticipated to provide lucrative opportunities to the market players.

The single cell analysis market is segmented into product, application, techniques, end user and region. According to product, the market is categorized into consumables and instruments. By application, it is segregated into oncology, immunology, neurology, stem cell, non-invasive prenatal diagnosis, In-vitro fertilization, others. According to techniques, the market is categorized into flow cytometry, next generation sequencing, polymerase chain reaction, mass spectrometry and others. On the basis of end user, it is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include: the Becton, Dickinson and Company, Danaher Corporation, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific, Inc., 10x Genomics, Illumina, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Sartorius AG, Takara Holdingsinc, Oxford Nanopore Technologies., Berkley Light INC., BGI Genomics Co.Ltd., Diasorin Group, Dolomite Bio, Standard Biotools.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the single cell analysis market analysis from 2021 to 2031 to identify the prevailing single cell analysis market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the single cell analysis market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global single cell analysis market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Consumables
Instruments

By Techniques

Flow Cytometry
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Mass Spectrometry
Others

By End User

Academic and Research Laboratories
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Others

By Application

Oncology
Immunology
Neurology
Stem cell
Non-Invasive Prenatal Diagnosis
In-Vitro Fertilization (IVF)
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- 10x Genomics
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Danaher Corporation(Cytiva Life Sciences)
- Illumina, Inc.
- BERKLEY LIGHTS INC
- BGI GENOMICS CO. LTD
- DIASORIN GROUP (LUMINEX CORPORATION)
- DOLOMITE BIO
- MERCK KGAA
- OXFORD NANAOPORE TECHNOLOGIES
- QIAGEN N.V
- Sartorius AG
- STANDARD BIOTOOLS (Fluidigm Corporation)
- TAKARA HOLDINGS INC
- THERMO FISHER SCIENTIFIC, INC.

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SINGLE CELL ANALYSIS MARKET, BY PRODUCT

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Consumables
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Instruments
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country

CHAPTER 5: SINGLE CELL ANALYSIS MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Oncology
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Immunology
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Neurology
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Stem cell
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
5.6 Non-Invasive Prenatal Diagnosis
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
5.7 In-Vitro Fertilization (IVF)
- 5.7.1 Key market trends, growth factors and opportunities
- 5.7.2 Market size and forecast, by region
- 5.7.3 Market analysis by country
5.8 Others
- 5.8.1 Key market trends, growth factors and opportunities
- 5.8.2 Market size and forecast, by region
- 5.8.3 Market analysis by country

CHAPTER 6: SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Flow Cytometry
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Next Generation Sequencing (NGS)
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Polymerase Chain Reaction (PCR)
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
6.5 Mass Spectrometry
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
6.6 Others
- 6.6.1 Key market trends, growth factors and opportunities
- 6.6.2 Market size and forecast, by region
- 6.6.3 Market analysis by country

CHAPTER 7: SINGLE CELL ANALYSIS MARKET, BY END USER

7.1 Overview
- 7.1.1 Market size and forecast
7.2 Academic and Research Laboratories
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
7.3 Biotechnology and Pharmaceutical Companies
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
7.4 Hospitals and Diagnostic Laboratories
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
7.5 Others
- 7.5.1 Key market trends, growth factors and opportunities
- 7.5.2 Market size and forecast, by region
- 7.5.3 Market analysis by country

CHAPTER 8: SINGLE CELL ANALYSIS MARKET, BY REGION

8.1 Overview
- 8.1.1 Market size and forecast
8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Product
- 8.2.3 North America Market size and forecast, by Application
- 8.2.4 North America Market size and forecast, by Techniques
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
  - 8.2.6.1 U.S.
  - 8.2.6.1.1 Market size and forecast, by Product
  - 8.2.6.1.2 Market size and forecast, by Application
  - 8.2.6.1.3 Market size and forecast, by Techniques
  - 8.2.6.1.4 Market size and forecast, by End User
  - 8.2.6.2 Canada
  - 8.2.6.2.1 Market size and forecast, by Product
  - 8.2.6.2.2 Market size and forecast, by Application
  - 8.2.6.2.3 Market size and forecast, by Techniques
  - 8.2.6.2.4 Market size and forecast, by End User
  - 8.2.6.3 Mexico
  - 8.2.6.3.1 Market size and forecast, by Product
  - 8.2.6.3.2 Market size and forecast, by Application
  - 8.2.6.3.3 Market size and forecast, by Techniques
  - 8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Product
- 8.3.3 Europe Market size and forecast, by Application
- 8.3.4 Europe Market size and forecast, by Techniques
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
  - 8.3.6.1 Germany
  - 8.3.6.1.1 Market size and forecast, by Product
  - 8.3.6.1.2 Market size and forecast, by Application
  - 8.3.6.1.3 Market size and forecast, by Techniques
  - 8.3.6.1.4 Market size and forecast, by End User
  - 8.3.6.2 France
  - 8.3.6.2.1 Market size and forecast, by Product
  - 8.3.6.2.2 Market size and forecast, by Application
  - 8.3.6.2.3 Market size and forecast, by Techniques
  - 8.3.6.2.4 Market size and forecast, by End User
  - 8.3.6.3 U.K.
  - 8.3.6.3.1 Market size and forecast, by Product
  - 8.3.6.3.2 Market size and forecast, by Application
  - 8.3.6.3.3 Market size and forecast, by Techniques
  - 8.3.6.3.4 Market size and forecast, by End User
  - 8.3.6.4 Italy
  - 8.3.6.4.1 Market size and forecast, by Product
  - 8.3.6.4.2 Market size and forecast, by Application
  - 8.3.6.4.3 Market size and forecast, by Techniques
  - 8.3.6.4.4 Market size and forecast, by End User
  - 8.3.6.5 Spain
  - 8.3.6.5.1 Market size and forecast, by Product
  - 8.3.6.5.2 Market size and forecast, by Application
  - 8.3.6.5.3 Market size and forecast, by Techniques
  - 8.3.6.5.4 Market size and forecast, by End User
  - 8.3.6.6 Rest of Europe
  - 8.3.6.6.1 Market size and forecast, by Product
  - 8.3.6.6.2 Market size and forecast, by Application
  - 8.3.6.6.3 Market size and forecast, by Techniques
  - 8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Product
- 8.4.3 Asia-Pacific Market size and forecast, by Application
- 8.4.4 Asia-Pacific Market size and forecast, by Techniques
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
  - 8.4.6.1 Japan
  - 8.4.6.1.1 Market size and forecast, by Product
  - 8.4.6.1.2 Market size and forecast, by Application
  - 8.4.6.1.3 Market size and forecast, by Techniques
  - 8.4.6.1.4 Market size and forecast, by End User
  - 8.4.6.2 China
  - 8.4.6.2.1 Market size and forecast, by Product
  - 8.4.6.2.2 Market size and forecast, by Application
  - 8.4.6.2.3 Market size and forecast, by Techniques
  - 8.4.6.2.4 Market size and forecast, by End User
  - 8.4.6.3 India
  - 8.4.6.3.1 Market size and forecast, by Product
  - 8.4.6.3.2 Market size and forecast, by Application
  - 8.4.6.3.3 Market size and forecast, by Techniques
  - 8.4.6.3.4 Market size and forecast, by End User
  - 8.4.6.4 Australia
  - 8.4.6.4.1 Market size and forecast, by Product
  - 8.4.6.4.2 Market size and forecast, by Application
  - 8.4.6.4.3 Market size and forecast, by Techniques
  - 8.4.6.4.4 Market size and forecast, by End User
  - 8.4.6.5 South Korea
  - 8.4.6.5.1 Market size and forecast, by Product
  - 8.4.6.5.2 Market size and forecast, by Application
  - 8.4.6.5.3 Market size and forecast, by Techniques
  - 8.4.6.5.4 Market size and forecast, by End User
  - 8.4.6.6 Rest of Asia-Pacific
  - 8.4.6.6.1 Market size and forecast, by Product
  - 8.4.6.6.2 Market size and forecast, by Application
  - 8.4.6.6.3 Market size and forecast, by Techniques
  - 8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Product
- 8.5.3 LAMEA Market size and forecast, by Application
- 8.5.4 LAMEA Market size and forecast, by Techniques
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
  - 8.5.6.1 Brazil
  - 8.5.6.1.1 Market size and forecast, by Product
  - 8.5.6.1.2 Market size and forecast, by Application
  - 8.5.6.1.3 Market size and forecast, by Techniques
  - 8.5.6.1.4 Market size and forecast, by End User
  - 8.5.6.2 Saudi Arabia
  - 8.5.6.2.1 Market size and forecast, by Product
  - 8.5.6.2.2 Market size and forecast, by Application
  - 8.5.6.2.3 Market size and forecast, by Techniques
  - 8.5.6.2.4 Market size and forecast, by End User
  - 8.5.6.3 South Africa
  - 8.5.6.3.1 Market size and forecast, by Product
  - 8.5.6.3.2 Market size and forecast, by Application
  - 8.5.6.3.3 Market size and forecast, by Techniques
  - 8.5.6.3.4 Market size and forecast, by End User
  - 8.5.6.4 Rest of LAMEA
  - 8.5.6.4.1 Market size and forecast, by Product
  - 8.5.6.4.2 Market size and forecast, by Application
  - 8.5.6.4.3 Market size and forecast, by Techniques
  - 8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES

10.1 10x Genomics
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
10.2 Agilent Technologies, Inc.
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
10.3 Becton, Dickinson and Company
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
10.4 Bio-Rad Laboratories
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
10.5 Danaher Corporation(Cytiva Life Sciences)
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
10.6 Illumina, Inc.
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
10.7 BERKLEY LIGHTS INC
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
10.8 BGI GENOMICS CO. LTD
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
10.9 DIASORIN GROUP (LUMINEX CORPORATION)
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
10.10 DOLOMITE BIO
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments
10.11 MERCK KGAA
- 10.11.1 Company overview
- 10.11.2 Company snapshot
- 10.11.3 Operating business segments
- 10.11.4 Product portfolio
- 10.11.5 Business performance
- 10.11.6 Key strategic moves and developments
10.12 OXFORD NANAOPORE TECHNOLOGIES
- 10.12.1 Company overview
- 10.12.2 Company snapshot
- 10.12.3 Operating business segments
- 10.12.4 Product portfolio
- 10.12.5 Business performance
- 10.12.6 Key strategic moves and developments
10.13 QIAGEN N.V
- 10.13.1 Company overview
- 10.13.2 Company snapshot
- 10.13.3 Operating business segments
- 10.13.4 Product portfolio
- 10.13.5 Business performance
- 10.13.6 Key strategic moves and developments
10.14 Sartorius AG
- 10.14.1 Company overview
- 10.14.2 Company snapshot
- 10.14.3 Operating business segments
- 10.14.4 Product portfolio
- 10.14.5 Business performance
- 10.14.6 Key strategic moves and developments
10.15 STANDARD BIOTOOLS (Fluidigm Corporation)
- 10.15.1 Company overview
- 10.15.2 Company snapshot
- 10.15.3 Operating business segments
- 10.15.4 Product portfolio
- 10.15.5 Business performance
- 10.15.6 Key strategic moves and developments
10.16 TAKARA HOLDINGS INC
- 10.16.1 Company overview
- 10.16.2 Company snapshot
- 10.16.3 Operating business segments
- 10.16.4 Product portfolio
- 10.16.5 Business performance
- 10.16.6 Key strategic moves and developments
10.17 THERMO FISHER SCIENTIFIC, INC.
- 10.17.1 Company overview
- 10.17.2 Company snapshot
- 10.17.3 Operating business segments
- 10.17.4 Product portfolio
- 10.17.5 Business performance
- 10.17.6 Key strategic moves and developments

単一細胞分析市場：製品別、技術別、エンドユーザー別、用途別：世界の機会分析および産業予測、2021-2031年

Single Cell Analysis Market By Product, By Techniques, By End User, By Application : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章単一細胞分析市場：製品別

第5章単一細胞分析市場：用途別

第6章単一細胞分析市場：技術別

第7章単一細胞分析市場：エンドユーザー別

第8章単一細胞分析市場：地域別

第9章企業情勢

第10章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: SINGLE CELL ANALYSIS MARKET, BY PRODUCT

CHAPTER 5: SINGLE CELL ANALYSIS MARKET, BY APPLICATION

CHAPTER 6: SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES

CHAPTER 7: SINGLE CELL ANALYSIS MARKET, BY END USER

CHAPTER 8: SINGLE CELL ANALYSIS MARKET, BY REGION

CHAPTER 9: COMPANY LANDSCAPE

CHAPTER 10: COMPANY PROFILES

単一細胞分析市場：製品別、技術別、エンドユーザー別、用途別：世界の機会分析および産業予測、2021-2031年

Single Cell Analysis Market By Product, By Techniques, By End User, By Application : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

第4章 単一細胞分析市場：製品別

第5章 単一細胞分析市場：用途別

第6章 単一細胞分析市場：技術別

第7章 単一細胞分析市場：エンドユーザー別

第8章 単一細胞分析市場：地域別

第9章 企業情勢

第10章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: SINGLE CELL ANALYSIS MARKET, BY PRODUCT

CHAPTER 5: SINGLE CELL ANALYSIS MARKET, BY APPLICATION

CHAPTER 6: SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES

CHAPTER 7: SINGLE CELL ANALYSIS MARKET, BY END USER

CHAPTER 8: SINGLE CELL ANALYSIS MARKET, BY REGION

CHAPTER 9: COMPANY LANDSCAPE

CHAPTER 10: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章単一細胞分析市場：製品別

第5章単一細胞分析市場：用途別

第6章単一細胞分析市場：技術別

第7章単一細胞分析市場：エンドユーザー別

第8章単一細胞分析市場：地域別

第9章企業情勢

第10章企業プロファイル